Skip to search formSkip to main contentSkip to account menu

ST1959

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Anti‐proliferative effect of a triazole derivative (ST1959) on LNCaP human prostate cancer cells through down‐regulation of cyclin and androgen receptor expression
Previous studies demonstrated that ST1959, a triazole derivative endowed with immunomodulatory activities, also exerts inhibitory… 
2007
2007
Dissecting drug and vehicle metabolic effects in rats by a metabonomic approach.
2005
2005
Effect of a Novel Immunosuppressant, ST1959, on the Immune System and Renal Allograft Survival in Rats
Background. ST1959 is a 3,5-diaryl-s-triazole belonging to a novel class of contragestional agents with immunosuppressant… 
2004
2004
Ameliorating effects of the immunomodulator 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole in an experimental model of colitis in the rat.
2004
2004
EFFECT OF A NOVEL IMMUNOSUPPRESSANT, ST1959, ON ALLOGENEIC IMMUNE RESPONSE AND RENAL ALLOGRAFT SURVIVAL IN RATS
2003
2003
Efficacy of ST1959 in murine models of autoimmunity and insights into its peculiar immunomodulatory profile
ST1959, formerly known as DL111-IT, is a contragestional agent of the triazole family, which has previously been reported to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)